A B S T R A C T The naturally occurring sulfidopeptide leukotrienes, leukotriene (LT) C4 (LTC4) [5(S)-hydroxy -6(R) -S -glutathionyl -7,9 -trans,1 1,14 -cis -eicosatetraenoic acid] and its cysteinylglycine (LTD4) and cysteinyl (LTE4) analogs, which are derived by peptide cleavage, differ in the concentrations required to elicit comparable contractions of the guinea pig ileum, with respective potencies of 1.2:5:1. The effect of the ongoing bioconversion of LTC4 and LTD4 on the contractile response of the guinea pig ileum to each was determined by recording the pattern of the contraction and quantitating the initial agonist and its metabolic products. The contraction was elicited by radiolabeled agonist, and its conversion products were sampled at defined intervals and resolved by their retention times on reverse-phase high performance liquid chromatography. After a latent period of 60 s, LTC4 initiated a linear response, followed by a slower, progressive response to a maximum level that was maintained without relaxation. The metabolic conversion of LTC4 was <5% during the linear phase of contraction and complete inhibition of bioconversion of LTC4 to LTD4 by the presence of serine-borate complex did not alter the pattern of the spasmogenic response. As the maximum response in the presence of serine-borate complex was three-quarters of that obtained without the inhibitor of bioconversion, the pre- Received for publication 23 August 1982 and in revised form 8 December 1982. dominant response was to LTC, itself. The spasmogenic response of the ileum to LTD4 was immediate, linear to a maximum level, and immediately followed by a marked relaxation. That the failure of LTD4 to sustain a contraction was due to its immediate, rapid, and quantitative conversion to the less potent LTE4 was established by pharmacologically inhibiting and anatomically deleting the converting activity. In the presence of L-cysteine the conversion of LTD4 to LTE4 was largely inhibited and the maximum contractile response was well maintained. After anatomic removal of the mucosa that contained the LTD4 dipeptidase activity, the longitudinal smooth muscle preparation gave a maximal response to LTD4 that was fully maintained. Thus, bioconversion is not a prerequisite for the spasmogenic activity of LTC4 and accounts for the transient response of the ileum to LTD4.
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INTRODUCTION
The C-6 sulfidopeptide leukotrienes (LT)' LTC4, LTD4 , and LTE4 together constitute the biological activity ascribed to slow reacting substance of anaphylaxis (1) (2) (3) (4) (5) . Their biosynthesis is initiated by the oxidative metabolism of arachidonic acid by 5-lipoxygenase to yield 5-hydroperoxyeicosatetraenoic acid, which is converted enzymatically to LTA4, 5-6-oxido-7,9-trans,l 1 ,14-cis-eicosatetraenoic acid (6) . LTC4, 5(S)-hydroxy-6(R)-S-glutathionyl-7,9-trans,1 1,14-ciseicosatetraenoic acid is formed via conjugation of ' Abbreviations used in this paper: LT, leukotriene; RPHPLC, reverse-phase high performance liquid chromatography.
LTA4 with glutathione by a glutathionyl-S-transferase (7) . Glutamic acid and glycine are sequentially cleaved from the glutathionyl domain at the C-6 to yield LTD4, 5(S)-hydroxy-6(R)-S-cysteinyl-glycine-7,9-trans,1 1 ,14-cis-eicosatetraenoic acid; and LTE4, 5(S)-hydroxy -6(R) -S -cysteinyl -7,9 -trans,1l,14 -ciseicosatetraenoic acid, respectively (2) (3) (4) (5) . Formation of the eicosatetraenoic acid metabolite, LTD4, and the eicosatrienoic acid metabolite, LTD3, by cleavage of glutamic acid from LTC4 and LTC3, respectively, has been demonstrated with partially purified y-glutamyl transpeptidase (8, 9) , and more recently with a homogeneous preparation of this enzyme (10) . Conversion of LTD4 to LTE4 by cleavage of the carboxy terminal glycine has been separately achieved with highly purified rat kidney dipeptidase and aminopeptidase (10) . LTC4 is also converted to LTD4 and to LTE4 in vitro by a number of cell types and tissue extracts (11) (12) (13) (14) (15) (16) and these bioconversions are suppressed by agents capable of inhibiting y-glutamyl transpeptidase and dipeptidases, respectively (9, 12, 17) .
In vitro studies of the amounts of agonist that are equally potent in eliciting spasmogenic activity have yielded molar ratios of LTC4/LTD4/LTE4 for guinea pig ileum of 4.2:1:5, for guinea pig parenchymal lung strips of 100:1:30 (18) , and of LTC4/LTD4 for human bronchial tissues of -1:1 (19, 20) . The molar ratio of LTC4/LTD4/LTE4 for amounts that are equally potent in decreasing human and guinea pig myocardial contractility are 25:1:265 and 10:1:2,000, respectively (21) . Thus, in in vitro studies, LTD4 is generally the most potent and LTE4 the least potent, but there is as much as a 2-log variation in the molar ratios of equal potencies with different tissues.
Possible explanations for these differences in relative potencies for the sulfidopeptide leukotrienes could relate to both receptor-determined and non-receptordetermined muscle functions. Receptor (25) and provided by New England Nuclear (Boston, MA).
Assay of biological activity. A 4-to 6-cm segment of distal guinea pig ileum or ileal longitudinal muscle strip was placed in an organ bath at 37°C for recording isotonic contractions in response to the sulfidopeptide leukotrienes (26) . Longitudinal muscle strips were prepared from the distal 10-cm segment of the ileum (27) 
RESULTS
Bioconversion of LTC4 and LTD4 by responding guinea pig terminal ileum. In each of four experiments with 5 ng of [3H]LTC4 (1 X 105 cpm), the contractile response was delayed 60 s in onset. The contraction was then linear to 2 min, progressed to a plateau at 30 min, and maintained this maximum for the remainder of the 50-min observation period (Fig. 1 (Fig. 2) . The maximum was not maintained and the response declined almost linearly from 1 to 6 min and then progressively until 11 min, at which point the response plateaued at -20% of maximum. The [3H]LTD4 declined in a linear fashion with time, with the conversion to [3H]LTE4 reaching 82% by 25 min. The recoveries of radiolabeled leukotrienes from the organ bath diffusate at each time point for the four experiments averaged 90±7%, and 76±10% of this activity was recovered after RPHPLC; no products other than LTD4 and LTE4 were detected. Inhibition of bioconversion of LTC4 to LTD4 by Lserine-borate complex and of LTD4 to LTE4 by Lcysteine. Because L-serine-borate complex and L-CySteine both contract the muscle preparation, a 15-min period was allowed after addition of either agent during which the muscle tension returned to base line. In two similar experiments with 5 ng of [3H]LTC4, the time course of response without and with L-serine-borate complex included a 1-min lag time, a linear brisk contraction from 1 to 2 min, a slower progressive contraction to a maximum, and a plateau with a slight decline out to 40 min (Fig. 3) . In the presence of Lserine-borate complex, the rate of contraction was lower and the maximum achieved was less than in its absence. Without the serine-borate complex, 20 and 30% of the [3H]LTC4 in the two experiments was converted to [3H]LTD4 and [3H]LTE4 at 40 min, whereas in the presence of inhibitor there was no apparent conversion in either experiment. The overall recoveries without and with serine-borate complex averaged 54 and 50% for the two experiments. In a separate experiment conducted in the presence of 1 mM serineborate complex, C-6 sulfidopeptide leukotrienes that were in the diffusate and associated with the tissue were separately analyzed 5 min after introduction of the radiolabeled LTC4. The diffusate contained 53.8% of the recovered counts, all of which were LTC4. The wash-buffer and the ethanolic extract of the tissue each contained <0.3% of the recovered counts and >90% of these counts eluted as LTC4; the residual tissue debris contained no measurable counts. After the contractile effect of the serine-borate complex had subsided, the presence of this inhibitor (10 mM) did not alter the contractile response of the smooth muscle to 50 ng of histamine or to 2 ng of LTD4.
The rates of the immediate linear contraction and the maximum amplitude evoked by 3.6 ng of [3H]LTD4 were not altered by the presence of 10 mM L-cysteine in three experiments. In the presence of L-cysteine, the maximum contraction was maintained for 4 min and declined to a plateau at two-thirds of the maximal response, whereas without cysteine the contraction was not maintained and declined rapidly to a plateau of one-sixth maximum. In the absence of the L-cysteine, the [3H]LTD4 was linearly and quantitatively converted to [3H]LTE4, whereas in the presence of L-Cysteine, [3H]LTD4 metabolism was <20%. The capacity of L-cysteine to minimize metabolism of [3H]LTD4, to prolong the maximum response, and to augment the plateau response as shown for one experiment (Fig. 4) , was similar in the two additional experiments. The overall recoveries without and with cysteine averaged 65 and 56.5%, respectively, for the three experiments.
Bioconversion of LTC4 and LTD4 by guinea pig ileum longitudinal muscle strips. The contractile response of a longitudinal muscle strip to 5 ng of
[3H]LTC4 included a 1-min delay, a linear contraction from 1 to 2 min, progression to a plateau at 25 min, and maintenance of this maximum contraction for the duration of observation to 45 min (Fig. 5) (Fig. 6) . Bioconversion of [3H]LTD4 was minimal at 30 min, reflecting the lack of the converting enzyme in the mucosa-free muscle preparations. The recoveries of radiolabeled leukotriene from the diffusates at each time point averaged 82.5% for the four experiments and 86% of this activity was recovered after RPHPLC; no products other than LTD4 and LTE4 were detected.
DISCUSSION
In order to characterize the effects of the associated bioconversion of LTC4 and LTD4 during the spas- (16, 22) . No products other than the sulfidopeptide leukotrienes were identified. That the bioconversions were not epiphenomena but were related to the muscle response was established by attenuating the metabolism of the C-6 sulfidopeptide leukotrienes with enzyme inhibitors and with anatomic deletion of the LTD4 dipeptidase activity from the responding muscle preparation. With these interventions it was possible to distinguish the time course of the onset of the intrinsic activity of LTC4 from that of LTD4 and to define the effect of metabolism on the persistence of the spasmogenic effect of each agonist. The response of the guinea pig ileum to [3H]LTC4 included a 60-s lag phase, a linear contraction to about two-thirds maximum over 60 s, and a slow further contraction to maximum, which was then maintained (Fig. 1) . As the metabolic conversion was <5% at 5 min, and was only 35% (8% LTD4 and 27% LTE4) at 50 min, the pattern of the response was attributed to LTC4 rather than to its conversion products. The introduction of serine-borate complex (28) completely prevented the bioconversion of LTC4 and reduced the maximum response to three-quarters of that observed without the inhibitor (Fig. 3) . Thus, on the guinea pig ileum, LTC4 has an inherent spasmogenic activity that is predominantly independent of its bioconversion to LTD4.
The spasmogenic response of the guinea pig ileum to LTD4 was immediate and progressed to a maximum at 60 s, which was maintained only briefly (Fig. 2) . A period of rapid relaxation was then followed by a plateau at -20% of the maximal contractile response. As the plot of the metabolic conversion of LTD4 to LTE4 was linear and passed through the origin, the conversion rate of 46.6 fmol/cm segment per min accounts for the transient nature of the maximal response to LTD4. The apparent lower rate of conversion of LTD4 to LTE4, as compared with the rate of muscle relaxation (Fig. 2) , most likely reflects the lag between tissue events and their presentation in the surrounding diffusate. Nonetheless, because of an equilibrium between association and dissociation of agonists, the contractile response observed does reflect the bioconversion and distribution of the agonists available for reassociation. This interpretation is supported by the finding of a more sustained contraction when the conversion of LTD4 to LTE4 was almost completely inhibited by the introduction of L-cysteine to the organ bath (Fig. 4) . With anatomical deletion of the LTD4 dipeptidase activity by removing the mucosa, the longitudinal smooth muscle preparation gave a contractile response to LTD4 that maintained its maximum (Fig. 6 ).
The spasmogenic response of the guinea pig ileum and that of the longitudinal smooth muscle preparation to LTC4 are delayed in onset by 1 min and are much more persistent than those occurring in response to LTD4. The different latency for initiation of the contractile response distinguishes the inherent activities of these leukotrienes and is not, as previously postulated, due to the requirement for the bioconversion of LTC4 to an active principle LTD4 (29, 30) , because the latent period for initiation of contraction was not altered by inhibition of this conversion. Further, the persistence of the LTC4 contraction at its maximum, as compared with the transient maximal response to LTD4, is due to resistance of the LTC4 to conversion to LTD4. which is in turn rapidly metabolized to LTE4. The conversion rate of LTC4 to LTD4 by a single longitudinal smooth muscle preparation is -5 fmol/ cm segment per min (Fig. 5 ) and compares favorably with an average value of 8 fmol/cm segment per min for the two-step conversion of LTC4 to LTE4 by the intact ileum, because the conversion of LTC4 to LTD4 is the rate-limiting step (Fig. 1) . In contrast, the conversion of LTD4 to LTE4 by the dipeptidase activity in the ileal preparation bearing mucosa was 46.6 fmol/ cm segment per min (Fig. 2) . The marked difference of the persistence of the contractile response to LTD4 in the absence of the mucosal LTD4 dipeptidase activity dramatically demonstrates that maintenance of a maximal response is determined by the continual integrity of the agonist and is not due to down-regulation by the muscle itself.
